About Taimei Technology
Taimei Technology is a company based in Pleasanton (United States) founded in 2013. Taimei Technology has raised $193.73 million across 4 funding rounds from investors including Tencent, Tiger Global and SBCVC. Taimei Technology operates in a competitive market with competitors including Medidata, Verily, TriNetX, Charles River Laboratories and Signant Health, among others.
- Headquarter Pleasanton, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zhejiang Taimei Medical Technology Co Ltd Class H
-
Annual Revenue
$76.94 M (USD)-5.64as on Dec 31, 2024
-
Net Profit
-$29.96 M (USD)39.28as on Dec 31, 2024
-
EBITDA
-$28.48 M (USD)40.73as on Dec 31, 2024
-
Total Equity Funding
$193.73 M (USD)
in 4 rounds
-
Latest Funding Round
$131.71 M (USD), Series E
Oct 18, 2019
-
Investors
Tencent
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Taimei Technology
Taimei Technology is a publicly listed company on the HKEX with ticker symbol 2576 in Hong Kong, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Taimei Technology
Unlock access to complete
Leadership Team
3 people
Product Management Team
1 people
Cto Team
1 people
Head Team
1 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Taimei Technology
Taimei Technology has successfully raised a total of $193.73M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $131.71 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series E — $131.7M
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Series E - Taimei Technology | Valuation | Tiger Global Management , Tencent | |
| Apr, 2018 | Amount | Series D - Taimei Technology | Valuation | ZSVC , SBCVC |
|
| Jan, 2017 | Amount | Series C - Taimei Technology | Valuation | Matrix Partners China , Northern Light Venture Capital |
|
Investors in Taimei Technology
Taimei Technology has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Tiger Global and SBCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture and private equity investments are managed with global diversification.
|
Founded Year | Domain | Location | |
|
China-based startups are invested in by SBCVC across diverse sectors.
|
Founded Year | Domain | Location | |
|
VC fund investing in startups
|
Founded Year | Domain | Location |
Investments & Acquisitions by Taimei Technology
Financial Statements - Taimei Technology
Taimei Technology Comparisons
Competitors of Taimei Technology
Taimei Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Charles River Laboratories and Signant Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| domain | founded_year | HQ Location |
AI-based solutions for health management are provided.
|
|
| domain | founded_year | HQ Location |
Clinical trial management software is provided for researchers and professionals.
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| domain | founded_year | HQ Location |
Paperless eSource and patient engagement solutions for clinical trials
|
Frequently Asked Questions about Taimei Technology
Taimei Technology was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Taimei Technology is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Taimei Technology is a funded company, having raised a total of $193.73M across 4 funding rounds to date. The company's 1st funding round was a Series C of $14.42M, raised on Jun 21, 2016.
Annual revenue of Taimei Technology is $76.94M as on Dec 31, 2024.
Taimei Technology was founded in 2013 and is based in Pleasanton, United States. Operations center on a digital intelligence platform within the life sciences sector. Services encompass TrialOS, a platform designed for clinical research support, and PharmaOS, a digital tool for collaborative marketing in the life and health industry. These offerings facilitate research and industry collaboration across relevant geographies.
Yes, Taimei Technology is publicly traded on HKEX under the ticker symbol 2576.
Taimei Technology has 11 investors. Key investors include Tencent, Tiger Global, SBCVC, Co-win Ventures, and Zhejiang Venture Capital.
The ticker symbol of Taimei Technology is 2576 on HKEX.